KalVista Pharmaceuticals Inc (KALV)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
T. Andrew Crockett
Employees:
100
ONE KENDALL SQUARE, BUILDING 200, STE. 2203, CAMBRIDGE, MA 02139
(857) 999-0075

KalVista Pharmaceuticals, Inc. discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME) products.

Data derived from most recent annual or quarterly report
Market Cap 193.499 Million Shares Outstanding24.618 Million Avg 30-day Volume 294.344 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.9
Price to Revenue0.0 Debt to Equity0.0 EBITDA-90.346 Million
Price to Book Value1.2204 Operating Margin0.0 Enterprise Value53.411 Million
Current Ratio16.555 EPS Growth-0.17 Quick Ratio14.793
1 Yr BETA 0.5986 52-week High/Low 17.06 / 4.12 Profit Margin0.0
Operating Cash Flow Growth-27.2864 Altman Z-Score4.4846 Free Cash Flow to Firm -73.778 Million
View SEC Filings from KALV instead.

View recent insider trading info

KalVista Pharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding KALV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KALV

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-02-23 by AUDHYA PAUL K.
  • 4: filed on 2023-02-23 by FEENER EDWARD P.
  • 4: filed on 2023-02-23 by YEA CHRISTOPHER
  • 4: filed on 2023-02-23 by PALLEIKO BENJAMIN L
  • 4: filed on 2023-02-23 by CROCKETT THOMAS ANDREW
  • 4: filed on 2022-11-21 by YEA CHRISTOPHER
  • 4: filed on 2022-11-21 by PALLEIKO BENJAMIN L
  • 4: filed on 2022-11-21 by FEENER EDWARD P.
  • 4: filed on 2022-11-21 by CROCKETT THOMAS ANDREW
  • 4: filed on 2022-11-21 by AUDHYA PAUL K.

    • Events (8k)

  • 8-K: filed on 2023-03-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-17:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-03-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-07:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    20 Thousand total shares from 5 transactions

    Exercise Derivative Conversion (M)

    37 Thousand total shares from 5 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PALLEIKO BENJAMIN L PRESIDENT, CFO, CBO & SEC'Y

    • Officer
    		 72,799 2023-02-17 4

    CROCKETT THOMAS ANDREW CEO

    • Officer
    • Director
    		 120,927 2023-02-17 5

    FEENER EDWARD P. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 64,352 2023-02-17 4

    YEA CHRISTOPHER CHIEF DEVELOPMENT OFFICER

    • Officer
    		 35,709 2023-02-17 4

    AUDHYA PAUL K. CHIEF MEDICAL OFFICER

    • Officer
    		 15,660 2023-02-17 4

    PEREIRA BRIAN JG

    • Director
    		 10,000 2022-10-13 1

    UNKART EDWARD W

    • Director
    		 10,000 2022-10-13 1

    CHA ALBERT

    • Director
    		 10,000 2022-10-13 1

    STUART NANCY

    • Director
    		 10,000 2022-10-13 1

    TREANOR PATRICK

    • Director
    		 17,000 2022-05-26 2

    SMITH MICHAEL DAVID SENIOR VP, DEVELOPMENT

    • Officer
    		 25,800 2022-05-17 1

    SOLAND DANIEL B

    • Director
    		 10,000 2021-09-30 0

    EDWARDS MARTIN

    • Director
    		 10,000 2021-09-30 0

    MAETZEL ANDREAS SENIOR VICE PRESIDENT, MEDICAL

    • Officer
    		 25,000 2021-05-26 0

    ORONSKY ARNOLD L

    • Director
    		 0 2020-10-01 0

    SVLSF IV, LLC

    SV LIFE SCIENCES FUND IV (GP), L.P.

    SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.

    SV LIFE SCIENCES FUND IV, L.P.

    • 10% Owner
    		 No longer subject to file 2019-04-08 0

    VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

    VHCP CO-INVESTMENT HOLDINGS II, LLC

    VHCP MANAGEMENT II, LLC

    VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

    VHCP CO-INVESTMENT HOLDINGS III, LLC

    VHCP MANAGEMENT III, LLC

    KOH BONG Y

    SHAH NIMISH P

    • 10% Owner
    		 No longer subject to file 2019-03-18 0

    ALDRICH RICHARD

    • Director
    		 0 2018-10-03 0

    RA CAPITAL MANAGEMENT, LLC

    KOLCHINSKY PETER

    • Director
    • 10% Owner
    		 1,441,070 2017-10-12 0

    SHAH RAJEEV M.

    • Director
    • 10% Owner
    		 1,441,070 2017-10-12 0

    NOVO HOLDINGS A/S

    • 10% Owner
    		 No longer subject to file 2017-10-10 0

    RESNICK JOSHUA

    • Director
    		 0 2017-09-27 0

    RA CAPITAL MANAGEMENT, LLC

    RA CAPITAL HEALTHCARE FUND LP

    KOLCHINSKY PETER

    • Director
    • 10% Owner
    		 0 2016-11-21 0

    BASTA STEVEN L

    • Director
    		 No longer subject to file 2016-11-21 0

    RENZI DAVID PRESIDENT & CEO

    • Officer
    • Director
    		 No longer subject to file 2016-11-21 0

    MARONEY MARCEE VP, CLINICAL AFFAIRS

    • Officer
    		 No longer subject to file 2016-11-21 0

    SAUL DAVID JOSEPH

    • Director
    		 0 2016-02-01 0

    GRAVETT DAVID M. VP, RESEARCH & DEVELOPMENT

    • Officer
    		 0 2016-01-04 0

    RAMIYA PREMCHANDRAN VICE PRESIDENT OF SUPPLY CHAIN

    • Officer
    		 0 2016-01-04 0

    MCKUNE JOHN SEE REMARKS

    • Officer
    		 0 2016-01-04 0

    CLAPPER DAVID M

    • Director
    		 0 2015-08-03 0

    KATKIN KEITH

    • Director
    		 0 2015-08-03 0

    LEWIS HAYLEY SEE REMARKS

    • Officer
    		 0 2015-08-03 0

    ZADNO REZA

    • Director
    		 0 2015-08-03 0

    ACMP IV LLC

    ACP IV, L.P.

    JANNEY DANIEL

    • 10% Owner
    		 4,343,550 2015-04-14 0

    NOHRA GUY P

    • Director
    		 4,343,550 2015-04-14 0

    INTERWEST MANAGEMENT PARTNERS IX, LLC

    INTERWEST PARTNERS IX, LP

    GIANOS PHILIP T

    ORONSKY ARNOLD L

    KLIMAN GILBERT H

    HOLMES W STEPHEN

    KJELLSON NINA S

    PEPPER DOUGLAS A

    CLEVELAND BRUCE A

    NASR KHALED

    • 10% Owner
    		 4,619,196 2015-04-14 0

    VIVO VENTURES VI, LLC

    VIVO VENTURES FUND VI, L.P.

    VIVO VENTURES VI AFFIILATES FUND, L.P.

    • 10% Owner
    		 8,401,760 2015-04-14 0

    WHITE THOMAS MICHAEL SEE REMARKS

    • Officer
    		 0 2015-04-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    YEA CHRISTOPHER - Officer CHIEF DEVELOPMENT OFFICER

    		2023-02-23 17:42:44 -0500 2023-02-17 S 2,727 $7.66 d 35,709 direct -2.4 8.9333 8.9333 6 -2.4 2

    CROCKETT THOMAS ANDREW - Director - Officer CEO

    		2023-02-23 17:40:48 -0500 2023-02-17 M 12,749 a 127,627 direct -2.4 8.9333 8.9333 6 -2.4 2

    CROCKETT THOMAS ANDREW - Director - Officer CEO

    		2023-02-23 17:40:48 -0500 2023-02-17 M 6,944 a 0 direct

    CROCKETT THOMAS ANDREW - Director - Officer CEO

    		2023-02-23 17:40:48 -0500 2023-02-17 S 6,700 $7.66 d 120,927 direct -2.4 8.9333 8.9333 6 -2.4 2

    CROCKETT THOMAS ANDREW - Director - Officer CEO

    		2023-02-23 17:40:48 -0500 2023-02-17 M 5,805 d 75,465 direct

    PALLEIKO BENJAMIN L - Officer PRESIDENT, CFO, CBO & SEC'Y

    		2023-02-23 17:41:42 -0500 2023-02-17 M 9,363 a 77,753 direct -2.4 8.9333 8.9333 6 -2.4 2

    PALLEIKO BENJAMIN L - Officer PRESIDENT, CFO, CBO & SEC'Y

    		2023-02-23 17:41:42 -0500 2023-02-17 M 6,944 d 0 direct

    PALLEIKO BENJAMIN L - Officer PRESIDENT, CFO, CBO & SEC'Y

    		2023-02-23 17:41:42 -0500 2023-02-17 S 4,954 $7.66 d 72,799 direct -2.4 8.9333 8.9333 6 -2.4 2

    PALLEIKO BENJAMIN L - Officer PRESIDENT, CFO, CBO & SEC'Y

    		2023-02-23 17:41:42 -0500 2023-02-17 M 2,419 d 31,444 direct

    YEA CHRISTOPHER - Officer CHIEF DEVELOPMENT OFFICER

    		2023-02-23 17:42:44 -0500 2023-02-17 M 4,204 a 38,436 direct -2.4 8.9333 8.9333 6 -2.4 2

    AUDHYA PAUL K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-23 17:44:53 -0500 2023-02-17 M 2,419 d 31,444 direct

    YEA CHRISTOPHER - Officer CHIEF DEVELOPMENT OFFICER

    		2023-02-23 17:42:44 -0500 2023-02-17 M 2,430 d 0 direct

    YEA CHRISTOPHER - Officer CHIEF DEVELOPMENT OFFICER

    		2023-02-23 17:42:44 -0500 2023-02-17 M 1,774 d 23,059 direct

    FEENER EDWARD P. - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-23 17:44:05 -0500 2023-02-17 M 4,204 a 66,580 direct -2.4 8.9333 8.9333 6 -2.4 2

    FEENER EDWARD P. - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-23 17:44:05 -0500 2023-02-17 M 2,430 d 0 direct

    FEENER EDWARD P. - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-23 17:44:05 -0500 2023-02-17 S 2,228 $7.66 d 64,352 direct -2.4 8.9333 8.9333 6 -2.4 2

    FEENER EDWARD P. - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-23 17:44:05 -0500 2023-02-17 M 1,774 d 23,059 direct

    AUDHYA PAUL K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-23 17:44:53 -0500 2023-02-17 M 6,446 a 6,313 direct -2.4 8.9333 8.9333 6 -2.4 2

    AUDHYA PAUL K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-23 17:44:53 -0500 2023-02-17 M 4,027 d 0 direct

    AUDHYA PAUL K. - Officer CHIEF MEDICAL OFFICER

    		2023-02-23 17:44:53 -0500 2023-02-17 S 3,412 $7.66 d 9,347 direct -2.4 8.9333 8.9333 6 -2.4 2

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 22:15:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 21:45:05 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 21:15:03 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 20:45:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 20:15:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 19:45:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 19:15:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 18:45:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 18:15:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 17:45:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 17:15:03 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 16:45:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 16:15:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 15:45:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 15:15:03 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 14:45:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 14:15:04 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 13:45:03 UTC 4.4119 0.4081 2800000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 13:15:03 UTC 4.4119 0.4081 2700000
    KALVISTA PHARMACEUTICALS INC KALV 2023-03-31 12:45:03 UTC 4.4119 0.4081 2700000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Christopher L. Jacobs republican House Filing 2023-01-10 2022-12-12 P $1,001-$15,000

    Elevate your investments